Zydus Lifesciences Ltd.
BSE: 532321 | NSE: ZYDUSLIFE
Mid Cap | Pharmaceuticals & Drugs
930.00
-17.10 (-1.81%) Cadila Healthcare informs about copy of Press Release
Date: 24-06-2015Cadila Healthcare has submitted a copy of Press Release dated June 24, 2015 titled ‘Zydus receives final approval for Pyridostigmine Bromide Tablets’
The above information is a part of company’s filings submitted to BSE.